Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aster DM Quality CareNSE:ASTERDM +0.17%77 EV-to-EBITDA is 72.36 as of Jul. 25, 2026, which is 525% above its 10-year median of 11.58. GuruFocus rates NSE:ASTERDM with a GF Score™ of 77/100 and a GF Value™ of ₹717.75 (Fairly Valued). The stock has 7 warning signs investors should review. Among 507 Healthcare Providers & Services companies, Aster DM Quality Care ranks worse than 94.08% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Aster DM Quality Care's enterprise value is ₹692,386 Mil.
Aster DM Quality Care's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was ₹9,569 Mil. Therefore, Aster DM Quality Care's EV-to-EBITDA for today is 72.36.
The historical rank and industry rank for Aster DM Quality Care's EV-to-EBITDA or its related term are showing as below:
NSE:ASTERDM'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.94 Med: 11.58 Max: 156.72
Current: 72.36
During the past 12 years, the highest EV-to-EBITDA of Aster DM Quality Care was 156.72. The lowest was 3.94. And the median was 11.58.
NSE:ASTERDM's EV-to-EBITDA is ranked worse than 94.08% of 507
companies
in the Healthcare Providers & Services industry
Industry Median: 10.92
vs NSE:ASTERDM: 72.36
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Aster DM Quality Care (NSE:ASTERDM) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Aster DM Quality Care's PE Ratio (TTM) for today is calculated as:
Aster DM Quality Care's share price for today is ₹785.65.
Aster DM Quality Care's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹7.530.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
Aster DM Quality Care EV-to-EBITDA Historical Data
* Premium members only.
The historical data trend for Aster DM Quality Care's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ASTERDM vs HCA, THC, DVA: EV-to-EBITDA Comparison
For the Medical Care Facilities subindustry, Aster DM Quality Care's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aster DM Quality Care EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Aster DM Quality Care's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Aster DM Quality Care's EV-to-EBITDA falls into.
Aster DM Quality Care's current Enterprise Value is ₹692,386 Mil.
Aster DM Quality Care's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹9,569 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aster DM Quality Care (NSE:ASTERDM) has a EV-to-EBITDA of 72.36 as of Jul. 25, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Aster DM Quality Care. This is 525% above median its historical median of 11.58. Over the past decade, Aster DM Quality Care's EV-to-EBITDA has ranged from 3.94 to 156.72. According to the industry distribution chart, Aster DM Quality Care ranks #477 out of 507 companies in the Healthcare Providers & Services industry, placing it in the top 94.1%.
Is Aster DM Quality Care's EV-to-EBITDA too high?
Aster DM Quality Care's current EV-to-EBITDA of 72.36 is 525% above median its 10-year median of 11.58. Over the past 10 years, this metric has ranged from a low of 3.94 to a high of 156.72. The Healthcare Providers & Services industry median EV-to-EBITDA is 10.92. Aster DM Quality Care's value of 72.36 is 562.6% above this industry median. Based on the distribution chart, Aster DM Quality Care ranks #477 out of 507 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Aster DM Quality Care has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Aster DM Quality Care's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Aster DM Quality Care ranks #477 out of 507 companies for EV-to-EBITDA. This places Aster DM Quality Care in the lower half of its industry. The industry median EV-to-EBITDA is 10.92. Aster DM Quality Care's value of 72.36 is 562.6% above this benchmark. Historically, Aster DM Quality Care's own EV-to-EBITDA has ranged from 3.94 to 156.72 over the past decade. While the company's 10-year median is 11.58 vs. the industry median of 10.92, Aster DM Quality Care has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.92, based on 507 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aster DM Quality Care's current EV-to-EBITDA of 72.36 is 562.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Aster DM Quality Care. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.92 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aster DM Quality Care's current EV-to-EBITDA is 72.36, which is 525% above median its own 10-year median of 11.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aster DM Quality Care stock overvalued right now?
Based on GuruFocus' analysis, Aster DM Quality Care (NSE:ASTERDM) is currently considered Fairly Valued. The stock's GF Value™ is ₹717.75, compared to a current price of ₹785.65 — trading 9.5% above its estimated fair value. The current EV-to-EBITDA is 72.36, which is 525% above median its 10-year median of 11.58 and 562.6% above the Healthcare Providers & Services industry median of 10.92. Aster DM Quality Care's overall GF Score™ is 77/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Aster DM Quality Care (NSE:ASTERDM), the current EV-to-EBITDA is 72.36 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aster DM Quality Care (NSE:ASTERDM) Overvalued in 2026?
Based on GuruFocus' analysis, Aster DM Quality Care stock appears to be overvalued.
The current stock price of ₹785.65 is trading 9.5% above its estimated GF Value™ of ₹717.75.
GuruFocus considers Aster DM Quality Care to be Fairly Valued.
Key valuation signals for NSE:ASTERDM:
EV-to-EBITDA: 72.36 (525% above median its 10-year median of 11.58)
GF Value™: ₹717.75 vs. price of ₹785.65 (9.5% above fair value)
Industry Position: 562.6% above the Healthcare Providers & Services median (#477 of 507)
No single metric tells the full story. See the NSE:ASTERDM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aster DM Healthcare Ltd is an India-based integrated healthcare provider. The group operates a comprehensive healthcare network comprising approximately 19 hospitals, 10 clinics, over 200 pharmacies, and more than 255 diagnostic laboratories across states. Its business segments include Hospitals, Clinics, Retail Pharmacies, and Others, with the majority of revenue derived from the Hospitals segment. Aster has been delivering high-quality care from primary to quaternary through dedicated personnel across clinical and non-clinical roles. Aster has a presence in metropolitan as well as Tier II and Tier III cities, and is committed to providing advanced and accessible healthcare in line with global standards, guided by a patient-first approach.
77GF Score
Get the complete analysis for NSE:ASTERDM
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ASTERDM has been successfully added to your 
